Vu A Tran, MD
Sleep Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 24
- 7 carriers
- Offices
- 3
Offices
3 locations · Aretaeus Telemedicine Inc · 17 clinicians in this group
Hospitals listed: Mercy Medical Center · Providence Santa Rosa Memorial Hospital · Sutter Santa Rosa Regional Hospital. That is not proof they admit you there this week.
Plans that list them
24 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tran’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
24 of 24 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A79456 · Current
Licensed to practise in California · since 2002 · expires 2027-08-31 · University of Vermont College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mercy Medical CenterMerced, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.364, Oct 2024 – Sep 2025
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
- Sutter Santa Rosa Regional HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for Mercy Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 1 worse of 6 measures. Safety: 3 better, 3 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.364 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.1 (0.11 to 2.09) · 798 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.74 (0.37 to 1.11) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 449 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.5 · 544 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 206 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 1,843 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 5,594 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 5,647 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.53 (0.28 to 4.78) · 763 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.35) · 161 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.96 (0.37 to 3.55) · 791 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.67 (0 to 16.88) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.84 (0.67 to 9.02) · 115 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.92 (0.46 to 3.38) · 273 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,979 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.764 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 31 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 477 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 62.8 · 511 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 43.6 · 554 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 462 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.8 to 8.2) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (8 to 14.1) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 196 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.2 to 19) · 70 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 413 cases | No different | Jan 2024 – Dec 2024 |
What patients said (394 patients answered, 11% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 2 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Sutter Santa Rosa Regional Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.08 to 1.99) · 1,147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.69 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.53 (108.3 to 216.76) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 316 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,971 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.47) · 4,946 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,974 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.99 (2.93 to 7.06) · 1,288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.15) · 532 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.82 to 3.9) · 1,214 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.87 (2.35 to 17.39) · 558 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.01 (4.29 to 11.73) · 522 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 337 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.89) · 4,064 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 206 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.626 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.299 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 342 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.1 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14 · 352 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.4 · 309 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 309 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5.1 to 9.8) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.8 to 15) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.8 to 18) · 1,275 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 702 cases | No different | Jan 2024 – Dec 2024 |
What patients said (752 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$679,948
Medicare paid this office $679,948 for 667 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 339 | $75,889 | $109 |
| Injection, inclisiran, 1 mg | 16 | $45,664 | None |
| Sleep study in sleep lab (6 years or older) | 76 | $44,714 | $566 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 64 | $43,015 | $633 |
| Injection, denosumab, 1 mg | 20 | $26,800 | None |
See all 22 services
| Return visit (30+ min) | 339 | $75,889 | $109 |
| Injection, inclisiran, 1 mg | 16 | $45,664 | None |
| Sleep study in sleep lab (6 years or older) | 76 | $44,714 | $566 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 64 | $43,015 | $633 |
| Injection, denosumab, 1 mg | 20 | $26,800 | None |
| Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | 288 | $22,407 | $47 |
| New patient visit (45+ min) | 154 | $21,898 | $142 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 39 | $21,678 | $53 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 39 | $19,450 | $49 |
| Long return visit (40+ min) | 87 | $15,975 | $141 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 38 | $15,073 | $38 |
| Therapy procedure using a positive pressure ventilator | 135 | $11,755 | $64 |
| Sleep study including heart rate, breathing, and sleep time | 62 | $10,409 | $141 |
| Test to examine how well the lungs exchange gases | 114 | $6,340 | $54 |
| Administration of chemotherapy into vein, 1 hour or less | 12 | $5,640 | $141 |
| Test to determine lung volumes using gas dilution or washout | 112 | $4,746 | $41 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 113 | $4,290 | $37 |
| Injection of drug or substance under skin or into muscle | 68 | $2,570 | $14 |
| Test for exercise-induced lung stress | 62 | $2,104 | $29 |
| New patient visit (60+ min) | 11 | $1,518 | $138 |
| Sleep study including heart rate, breathing, airflow, and effort | 11 | $1,193 | $80 |
| Test to measure oxygen level in blood using ear or finger device continuously overnight | 21 | $557 | $25 |
Who their Medicare patients are
667 Original Medicare patients in 2024. Average age 76 · Under 65 2% · 85 and older 12% · Women 55% · Also on Medicaid 42% · Health risk score 1.38. Above the middle of the specialty; the typical sleep medicine clinician is at 1.21.
Conditions among them: High blood pressure 75% · Diabetes 37% · Coronary heart disease 35% · COPD 33% · Chronic kidney disease 26% · Atrial fibrillation 21% · Heart failure 19% · Depression 16% · Cancer 12% · Dementia 9% · Stroke 7%.
The office billed $2,421,048, Medicare allowed $861,272 and paid $679,948; for 53,082 services of 43 kinds; $346,326 of it was for drugs given in the office and $333,622 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 667 | 53,082 | 76 | 1.38 | $2,421,048 | $679,948 |
| 2023 | 506 | 3,461 | 76 | 1.30 | $1,084,773 | $306,891 |
| 2022 | 445 | 3,517 | 75 | 1.30 | $1,056,758 | $322,912 |
| 2021 | 438 | 2,551 | 75 | 1.58 | $895,646 | $306,088 |
| 2020 | 422 | 2,367 | 75 | 1.70 | $669,196 | $229,982 |
| 2019 | 379 | 1,896 | 74 | 1.48 | $621,490 | $204,571 |
| 2018 | 563 | 1,724 | 73 | 1.43 | $772,979 | $200,169 |
| 2017 | 641 | 2,051 | 73 | 1.30 | $803,794 | $204,328 |
| 2016 | 695 | 1,926 | 72 | 1.35 | $1,017,393 | $262,265 |
| 2015 | 594 | 1,730 | 72 | 1.39 | $988,256 | $266,671 |
| 2014 | 549 | 1,700 | 71 | 1.35 | $1,083,559 | $293,703 |
| 2013 | 363 | 1,098 | 72 | 1.34 | $670,202 | $177,557 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Return visit (30+ min) | 287 | $64,451 | $112 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 79 | $55,112 | $641 |
| Sleep study in sleep lab (6 years or older) | 59 | $38,516 | $602 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 77 | $30,130 | $53 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 78 | $28,167 | $46 |
| New patient visit (45+ min) | 145 | $21,656 | $149 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 73 | $21,428 | $36 |
| Therapy procedure using a positive pressure ventilator | 101 | $10,189 | $63 |
| Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | 142 | $8,813 | $47 |
| Sleep study including heart rate, breathing, and sleep time | 37 | $6,198 | $155 |
| Test to examine how well the lungs exchange gases | 72 | $4,168 | $58 |
| Test to determine lung volumes using gas dilution or washout | 72 | $3,075 | $43 |
| Telephone medical discussion with physician, 21-30 minutes | 22 | $2,862 | $110 |
| New patient visit (60+ min) | 20 | $2,847 | $142 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 72 | $2,750 | $38 |
| Test for exercise-induced lung stress | 74 | $2,252 | $30 |
| Sleep study including heart rate, breathing, airflow, and effort | 15 | $1,419 | $79 |
| Test to measure oxygen level in blood using ear or finger device continuously overnight | 42 | $1,059 | $25 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 12 | $250 | $21 |
2022: 21 services
| Return visit (30+ min) | 274 | $74,334 | $109 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 67 | $45,021 | $634 |
| Sleep study in sleep lab (6 years or older) | 70 | $44,466 | $585 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 76 | $25,624 | $55 |
| Extended patient service without direct patient contact, first hour | 141 | $23,639 | $96 |
| New patient visit (45+ min) | 151 | $21,038 | $139 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 76 | $18,435 | $47 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 68 | $14,306 | $37 |
| Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | 173 | $12,557 | $46 |
| Therapy procedure using a positive pressure ventilator | 73 | $7,771 | $63 |
| Test to examine how well the lungs exchange gases | 82 | $4,827 | $59 |
| Sleep study including heart rate, breathing, and sleep time | 18 | $3,742 | $170 |
| Test to determine lung volumes using gas dilution or washout | 83 | $3,562 | $43 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 14 | $3,410 | $118 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 83 | $3,166 | $38 |
| Sleep study including heart rate, breathing, airflow, and effort | 31 | $3,112 | $86 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $2,684 | $103 |
| Test for exercise-induced lung stress | 68 | $2,248 | $29 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 21 | $1,989 | $55 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 68 | $1,483 | $19 |
| Test to measure oxygen level in blood using ear or finger device continuously overnight | 44 | $1,195 | $26 |
2021: 20 services
| Return visit (30+ min) | 258 | $72,969 | $112 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 75 | $52,954 | $638 |
| Sleep study in sleep lab (6 years or older) | 61 | $38,046 | $614 |
| Critical care, first 30-74 minutes | 12 | $36,916 | $184 |
| New patient visit (45+ min) | 162 | $23,232 | $143 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $18,472 | $88 |
| Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | 169 | $13,372 | $49 |
| Therapy procedure using a positive pressure ventilator | 70 | $7,332 | $63 |
| Test to examine how well the lungs exchange gases | 120 | $7,105 | $58 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 120 | $5,437 | $45 |
| Test to determine lung volumes using gas dilution or washout | 120 | $5,105 | $42 |
| Test for exercise-induced lung stress | 98 | $3,808 | $30 |
| Extended patient service without direct patient contact, first hour | 35 | $3,762 | $96 |
| Sleep study including heart rate, breathing, airflow, and effort | 30 | $3,450 | $96 |
| Telephone medical discussion with physician, 21-30 minutes | 27 | $3,205 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,193 | $169 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 12 | $1,462 | $70 |
| Test to measure oxygen level in blood using ear or finger device continuously overnight | 46 | $1,296 | $27 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 12 | $1,058 | $50 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 12 | $252 | $21 |
2020: 14 services
| Return visit (30+ min) | 226 | $44,884 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $41,249 | $89 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 48 | $33,410 | $630 |
| New patient visit (45+ min) | 176 | $24,652 | $140 |
| Sleep study in sleep lab (6 years or older) | 39 | $23,424 | $601 |
| Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | 143 | $9,521 | $47 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 118 | $6,860 | $58 |
| Test to examine how well the lungs exchange gases | 118 | $6,593 | $55 |
| Therapy procedure using a positive pressure ventilator | 67 | $6,490 | $54 |
| Sleep study including heart rate, breathing, airflow, and effort | 45 | $6,024 | $100 |
| Test to determine lung volumes using gas dilution or washout | 118 | $5,021 | $42 |
| Test for exercise-induced lung stress | 109 | $4,041 | $29 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,826 | $166 |
| Test to measure oxygen level in blood using ear or finger device continuously overnight | 70 | $1,920 | $25 |
2019: 17 services
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 61 | $44,623 | $620 |
| Return visit (30+ min) | 193 | $36,985 | $92 |
| Sleep study in sleep lab (6 years or older) | 45 | $27,124 | $590 |
| New patient visit (45+ min) | 153 | $20,885 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $19,125 | $87 |
| Sleep study including heart rate, breathing, airflow, and effort | 70 | $10,424 | $78 |
| Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | 135 | $9,595 | $49 |
| Therapy procedure using a positive pressure ventilator | 77 | $8,423 | $59 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 88 | $4,996 | $54 |
| Test to examine how well the lungs exchange gases | 89 | $4,621 | $50 |
| Test to determine lung volumes using gas dilution or washout | 89 | $3,663 | $39 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,212 | $169 |
| Return visit (30+ min) | 39 | $3,102 | $66 |
| Test for exercise-induced lung stress | 84 | $3,021 | $29 |
| New patient visit (45+ min) | 24 | $2,187 | $91 |
| Long return visit (40+ min) | 12 | $1,494 | $124 |
| Test to measure oxygen level in blood using ear or finger device continuously overnight | 29 | $760 | $23 |
2018: 13 services
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 99 | $63,881 | $603 |
| Sleep study in sleep lab (6 years or older) | 75 | $46,161 | $607 |
| Return visit (30+ min) | 269 | $27,259 | $78 |
| New patient visit (45+ min) | 200 | $24,092 | $120 |
| Sleep study including heart rate, breathing, airflow, and effort | 85 | $14,368 | $141 |
| Therapy procedure using a positive pressure ventilator | 130 | $9,559 | $53 |
| Test for exercise-induced lung stress | 116 | $3,538 | $28 |
| Short return visit (20+ min) | 44 | $2,328 | $52 |
| Test to determine lung volumes using sensors | 104 | $1,037 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 95 | $1,013 | $11 |
| Test to measure oxygen level in blood using ear or finger device continuously overnight | 45 | $930 | $20 |
| Test to measure the level of nitric oxide gas | 54 | $812 | $13 |
| Test to examine how well the lungs exchange gases | 105 | $776 | $7 |
2017: 13 services
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 93 | $57,472 | $575 |
| Sleep study in sleep lab (6 years or older) | 85 | $47,979 | $558 |
| Return visit (30+ min) | 281 | $32,513 | $79 |
| New patient visit (45+ min) | 226 | $25,927 | $115 |
| Therapy procedure using a positive pressure ventilator | 214 | $15,096 | $48 |
| Sleep study including heart rate, breathing, airflow, and effort | 75 | $10,732 | $126 |
| Pulmonary exercise testing | 94 | $4,826 | $46 |
| Test to measure the level of nitric oxide gas | 153 | $3,106 | $16 |
| Short return visit (20+ min) | 27 | $1,481 | $51 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 142 | $1,477 | $10 |
| Test to determine lung volumes using sensors | 149 | $1,467 | $10 |
| Test to examine how well the lungs exchange gases | 153 | $1,110 | $7 |
| Test to measure expiratory airflow and volume | 14 | $94 | $7 |
2016: 14 services
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 145 | $91,921 | $571 |
| Sleep study in sleep lab (6 years or older) | 115 | $63,351 | $546 |
| Return visit (30+ min) | 288 | $31,107 | $77 |
| New patient visit (45+ min) | 210 | $27,081 | $129 |
| Sleep study including heart rate, breathing, airflow, and effort | 95 | $13,447 | $134 |
| Therapy procedure using a positive pressure ventilator | 161 | $12,029 | $52 |
| New patient visit (60+ min) | 86 | $11,720 | $136 |
| Short return visit (20+ min) | 81 | $4,451 | $49 |
| New patient visit (15+ min) | 30 | $2,033 | $68 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 151 | $1,590 | $10 |
| Test to determine lung volumes using sensors | 153 | $1,512 | $10 |
| Test to examine how well the lungs exchange gases | 152 | $1,118 | $7 |
| Pulmonary exercise testing | 11 | $551 | $46 |
| Test to measure the level of nitric oxide gas | 11 | $176 | $16 |
2015: 12 services
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 150 | $94,049 | $595 |
| Sleep study in sleep lab (6 years or older) | 127 | $73,785 | $581 |
| Return visit (30+ min) | 270 | $35,461 | $80 |
| New patient visit (45+ min) | 227 | $27,519 | $121 |
| New patient visit (60+ min) | 60 | $10,103 | $168 |
| Therapy procedure using a positive pressure ventilator | 93 | $8,200 | $57 |
| Short return visit (20+ min) | 121 | $8,061 | $55 |
| Sleep study including heart rate, breathing, airflow, and effort | 27 | $4,076 | $146 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 122 | $1,329 | $11 |
| Test to determine lung volumes using sensors | 122 | $1,255 | $10 |
| Test to examine how well the lungs exchange gases | 122 | $930 | $7 |
| New patient visit (15+ min) | 13 | $923 | $71 |
2014: 11 services
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 166 | $110,522 | $601 |
| Sleep study in sleep lab (6 years or older) | 157 | $91,861 | $578 |
| New patient visit (60+ min) | 186 | $29,833 | $160 |
| Return visit (30+ min) | 222 | $26,707 | $83 |
| Long return visit (40+ min) | 145 | $20,175 | $101 |
| Therapy procedure using a positive pressure ventilator | 52 | $5,217 | $59 |
| Short return visit (20+ min) | 44 | $2,585 | $54 |
| Test to determine lung volumes using sensors | 150 | $1,507 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 143 | $1,463 | $10 |
| Test to examine how well the lungs exchange gases | 150 | $1,109 | $7 |
| Test to measure expiratory airflow and volume | 20 | $117 | $6 |
2013: 9 services
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 85 | $52,473 | $577 |
| Sleep study in sleep lab (6 years or older) | 90 | $52,016 | $578 |
| Long return visit (40+ min) | 169 | $36,199 | $109 |
| New patient visit (60+ min) | 127 | $19,341 | $152 |
| Return visit (30+ min) | 118 | $13,513 | $80 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 85 | $885 | $10 |
| Test to determine lung volumes using sensors | 85 | $877 | $10 |
| Test to examine how well the lungs exchange gases | 86 | $658 | $8 |
| Short return visit (20+ min) | 12 | $654 | $55 |
Medicaid work
$5,166 in 2024
Medicaid paid $5,166 for 1,192 billed services this clinician did in 2024, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 206 | $1,166 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 207 | $857 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 69 | $813 |
| Return visit (30+ min) | 187 | $778 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; each additional 20 minutes (List separately in addition to code for primary procedure) | 206 | $673 |
| New patient visit (45+ min) | 74 | $532 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bilevel ventilation, attended by a technologist | 14 | $179 |
| Continuous positive airway pressure ventilation (CPAP), initiation and management | 108 | $119 |
| Collection and interpretation of physiologic data (eg, ECG, blood pressure, glucose monitoring) digitally stored and/or transmitted by the patient and/or caregiver to the physician or other qualified health care professional, qualified by education, training, licensure/regulation (when applicable) requiring a minimum of 30 minutes of time, each 30 days | 34 | $20 |
| EVALUATION OF WHEEZING | 29 | $12 |
| Diffusing capacity | 29 | $9 |
| Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes | 29 | $7 |
| 2024 | 1,192 | 12 | 28 | $5,166 |
| 2023 | 1,588 | 9 | 42 | $6,019 |
| 2022 | 690 | 7 | 24 | $627 |
| 2021 | 120 | 4 | 19 | $0 |
| 2020 | 105 | 5 | 18 | $220 |
See the largest Medicaid services in earlier years
2023
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 310 | $1,851 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 301 | $1,345 |
| Return visit (30+ min) | 335 | $1,131 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; each additional 20 minutes (List separately in addition to code for primary procedure) | 289 | $1,020 |
| Continuous positive airway pressure ventilation (CPAP), initiation and management | 216 | $224 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bilevel ventilation, attended by a technologist | 25 | $180 |
| New patient visit (45+ min) | 41 | $170 |
| Collection and interpretation of physiologic data (eg, ECG, blood pressure, glucose monitoring) digitally stored and/or transmitted by the patient and/or caregiver to the physician or other qualified health care professional, qualified by education, training, licensure/regulation (when applicable) requiring a minimum of 30 minutes of time, each 30 days | 57 | $93 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 14 | $5 |
2022
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 101 | $284 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 101 | $203 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; each additional 20 minutes (List separately in addition to code for primary procedure) | 88 | $140 |
| Continuous positive airway pressure ventilation (CPAP), initiation and management | 106 | $0 |
| New patient visit (45+ min) | 13 | $0 |
| Return visit (30+ min) | 211 | $0 |
| PROLNG E/M SVC BEFORE&/AFTER DIR PT CARE 1ST HR | 70 | $0 |
2021
| Continuous positive airway pressure ventilation (CPAP), initiation and management | 66 | $0 |
| New patient visit (45+ min) | 24 | $0 |
| Return visit (30+ min) | 15 | $0 |
| PROLNG E/M SVC BEFORE&/AFTER DIR PT CARE 1ST HR | 15 | $0 |
2020
| New patient visit (45+ min) | 12 | $76 |
| Diffusing capacity | 25 | $53 |
| EVALUATION OF WHEEZING | 25 | $50 |
| Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes | 25 | $41 |
| Continuous positive airway pressure ventilation (CPAP), initiation and management | 18 | $0 |
Drugs they prescribed that Part D paid
$2,268,065
Pharmacies billed $2,268,065 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,136) in 2024. At or below the middle of the specialty; the typical sleep medicine clinician is at 0%.
1,721 generic and 1,415 brand-name prescriptions · $2,268,065 in drug cost · 202 antibiotic prescriptions to 153 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ofev | 65 | $761,292 | $11,712 |
| Trelegy Ellipta | 500 | $453,156 | $906 |
| Dupixent | 92 | $357,440 | $3,885 |
| Tezspire | 59 | $259,327 | $4,395 |
| Breztri Aerosphere | 149 | $108,972 | $731 |
See all 32 drugs
| Ofev | 65 | $761,292 | $11,712 |
| Trelegy Ellipta | 500 | $453,156 | $906 |
| Dupixent | 92 | $357,440 | $3,885 |
| Tezspire | 59 | $259,327 | $4,395 |
| Breztri Aerosphere | 149 | $108,972 | $731 |
| Breo Ellipta | 97 | $54,895 | $566 |
| Anoro Ellipta | 27 | $21,862 | $810 |
| Spiriva Respimat | 18 | $20,367 | $1,132 |
| Stiolto Respimat | 29 | $17,076 | $589 |
| Symbicort | 52 | $15,917 | $306 |
| Budesonide-Formoterol | 39 | $10,989 | $282 |
| Combivent Respimat | 19 | $10,132 | $533 |
| Montelukast | 698 | $7,934 | $11 |
| Arnuity Ellipta | 13 | $7,673 | $590 |
| Albuterol Sulfate Hfa | 123 | $7,054 | $57 |
| Breyna | 28 | $6,708 | $240 |
| Incruse Ellipta | 21 | $6,607 | $315 |
| Fluticasone-Salmeterol | 42 | $5,731 | $136 |
| Advair Hfa | 12 | $5,109 | $426 |
| Ventolin Hfa | 54 | $4,589 | $85 |
| Ipratropium | 188 | $4,189 | $22 |
| Varenicline | 16 | $3,597 | $225 |
| Wixela Inhub | 19 | $3,409 | $179 |
| Roflumilast | 31 | $2,620 | $85 |
| Levalbuterol Tartrate Hfa | 28 | $2,398 | $86 |
| Famotidine | 124 | $1,231 | $10 |
| Prednisone | 185 | $619 | $3 |
| Azithromycin | 156 | $575 | $4 |
| Bupropion Hcl Sr | 18 | $543 | $30 |
| Fluticasone Propionate | 37 | $488 | $13 |
| Amoxicillin-Clavulanate Potass | 29 | $391 | $13 |
| Pramipexole Dihydrochloride | 51 | $325 | $6 |
Year by year
| 2024 | 3,136 | 478 | 0% (0) | 45% | $2,268,065 |
| 2023 | 2,564 | 395 | 0% (0) | None | $1,935,707 |
| 2022 | 2,002 | 292 | 0% (0) | None | $902,323 |
| 2021 | 1,349 | 246 | None | 54% | $610,235 |
| 2020 | 1,123 | 205 | 0% (0) | 61% | $568,801 |
| 2019 | 920 | 185 | 0% (0) | 60% | $393,344 |
| 2018 | 1,513 | 235 | 0% (0) | 62% | $576,638 |
| 2017 | 1,626 | 250 | 0% (0) | 57% | $697,951 |
| 2016 | 1,375 | 222 | 0% (0) | 55% | $491,114 |
| 2015 | 1,161 | 189 | 0% (0) | 55% | $335,706 |
| 2014 | 1,020 | 177 | 0% (0) | 50% | $156,397 |
| 2013 | 755 | 133 | 0% (0) | 53% | $129,506 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 34 drugs
| Ofev | 56 | $776,727 | $13,870 |
| Dupixent | 86 | $319,794 | $3,719 |
| Trelegy Ellipta | 354 | $305,543 | $863 |
| Breztri Aerosphere | 120 | $103,421 | $862 |
| Tezspire | 14 | $69,785 | $4,985 |
| Symbicort | 85 | $48,910 | $575 |
| Spiriva Respimat | 40 | $26,179 | $654 |
| Stiolto Respimat | 40 | $20,812 | $520 |
| Breo Ellipta | 41 | $17,387 | $424 |
| Advair Diskus | 12 | $12,946 | $1,079 |
| Combivent Respimat | 18 | $12,629 | $702 |
| Anoro Ellipta | 14 | $11,937 | $853 |
| Montelukast | 627 | $11,776 | $19 |
| Flovent Hfa | 16 | $11,340 | $709 |
| Wixela Inhub | 13 | $9,945 | $765 |
| Daliresp | 12 | $8,897 | $741 |
| Incruse Ellipta | 19 | $8,035 | $423 |
| Roflumilast | 22 | $7,167 | $326 |
| Budesonide-Formoterol | 16 | $6,316 | $395 |
| Fluticasone-Salmeterol | 11 | $5,696 | $518 |
| Advair Hfa | 11 | $5,498 | $500 |
| Albuterol Sulfate Hfa | 90 | $4,841 | $54 |
| Ventolin Hfa | 44 | $4,340 | $99 |
| Ipratropium | 102 | $4,109 | $40 |
| Qvar Redihaler | 11 | $3,359 | $305 |
| Famotidine | 83 | $1,787 | $22 |
| Prednisone | 187 | $1,227 | $7 |
| Bupropion Hcl Sr | 30 | $1,067 | $36 |
| Azithromycin | 142 | $995 | $7 |
| Amoxicillin-Clavulanate Potass | 47 | $914 | $19 |
| Fluconazole | 12 | $790 | $66 |
| Pramipexole Dihydrochloride | 44 | $612 | $14 |
| Fluticasone Propionate | 17 | $201 | $12 |
| Glycopyrrolate | 11 | $145 | $13 |
2022: 29 drugs
| Ofev | 13 | $171,259 | $13,174 |
| Dupixent | 34 | $143,186 | $4,211 |
| Trelegy Ellipta | 208 | $137,336 | $660 |
| Dupixent | 25 | $87,070 | $3,483 |
| Symbicort | 152 | $77,364 | $509 |
| Breztri Aerosphere | 52 | $40,559 | $780 |
| Stiolto Respimat | 43 | $22,985 | $535 |
| Advair Diskus | 22 | $19,040 | $865 |
| Spiriva Respimat | 29 | $18,929 | $653 |
| Daliresp | 21 | $17,979 | $856 |
| Breo Ellipta | 41 | $16,403 | $400 |
| Anoro Ellipta | 25 | $15,829 | $633 |
| Montelukast | 497 | $9,773 | $20 |
| Flovent Hfa | 21 | $8,611 | $410 |
| Combivent Respimat | 12 | $8,416 | $701 |
| Flovent Diskus | 16 | $6,511 | $407 |
| Fluticasone-Salmeterol | 16 | $6,065 | $379 |
| Ventolin Hfa | 50 | $5,253 | $105 |
| Albuterol Sulfate Hfa | 62 | $4,436 | $72 |
| Budesonide-Formoterol | 13 | $4,320 | $332 |
| Wixela Inhub | 11 | $3,354 | $305 |
| Ipratropium | 65 | $2,704 | $42 |
| Azithromycin | 129 | $1,041 | $8 |
| Famotidine | 63 | $950 | $15 |
| Prednisone | 145 | $916 | $6 |
| Amoxicillin-Clavulanate Potass | 28 | $662 | $24 |
| Fluconazole | 14 | $553 | $40 |
| Pramipexole Dihydrochloride | 62 | $489 | $8 |
| Fluticasone Propionate | 14 | $282 | $20 |
2021: 23 drugs
| Dupixent | 30 | $98,558 | $3,285 |
| Trelegy Ellipta | 123 | $80,527 | $655 |
| Symbicort | 132 | $63,940 | $484 |
| Dupixent | 13 | $44,559 | $3,428 |
| Breztri Aerosphere | 39 | $27,861 | $714 |
| Spiriva Respimat | 34 | $25,963 | $764 |
| Stiolto Respimat | 33 | $19,854 | $602 |
| Spiriva | 14 | $19,636 | $1,403 |
| Anoro Ellipta | 34 | $19,372 | $570 |
| Daliresp | 23 | $18,335 | $797 |
| Breo Ellipta | 32 | $13,439 | $420 |
| Advair Diskus | 20 | $12,960 | $648 |
| Combivent Respimat | 18 | $10,975 | $610 |
| Chantix | 20 | $9,371 | $469 |
| Wixela Inhub | 18 | $8,635 | $480 |
| Pulmicort Flexhaler | 15 | $5,194 | $346 |
| Montelukast | 379 | $4,818 | $13 |
| Albuterol Sulfate Hfa | 71 | $4,566 | $64 |
| Ipratropium | 28 | $1,194 | $43 |
| Ventolin Hfa | 13 | $882 | $68 |
| Prednisone | 61 | $377 | $6 |
| Bupropion Hcl Sr | 13 | $326 | $25 |
| Azithromycin | 42 | $260 | $6 |
2020: 24 drugs
| Ofev | 14 | $140,518 | $10,037 |
| Dupixent | 35 | $111,136 | $3,175 |
| Trelegy Ellipta | 89 | $59,467 | $668 |
| Symbicort | 87 | $44,324 | $509 |
| Spiriva Respimat | 51 | $30,594 | $600 |
| Stiolto Respimat | 33 | $17,748 | $538 |
| Spiriva | 12 | $15,385 | $1,282 |
| Anoro Ellipta | 29 | $15,075 | $520 |
| Breo Ellipta | 37 | $15,039 | $406 |
| Daliresp | 26 | $14,589 | $561 |
| Chantix | 29 | $13,125 | $453 |
| Incruse Ellipta | 25 | $8,557 | $342 |
| Atrovent Hfa | 16 | $6,915 | $432 |
| Combivent Respimat | 12 | $6,867 | $572 |
| Wixela Inhub | 12 | $6,758 | $563 |
| Montelukast | 263 | $3,306 | $13 |
| Arnuity Ellipta | 13 | $2,352 | $181 |
| Albuterol Sulfate Hfa | 52 | $2,279 | $44 |
| Ventolin Hfa | 21 | $1,537 | $73 |
| Xopenex Hfa | 15 | $1,436 | $96 |
| Levalbuterol Tartrate Hfa | 12 | $655 | $55 |
| Azithromycin | 27 | $261 | $10 |
| Prednisone | 37 | $242 | $7 |
| Fluticasone Propionate | 18 | $108 | $6 |
2019: 18 drugs
| Dupixent | 30 | $100,225 | $3,341 |
| Symbicort | 78 | $39,427 | $505 |
| Trelegy Ellipta | 53 | $33,302 | $628 |
| Spiriva Respimat | 49 | $33,143 | $676 |
| Spiriva | 21 | $16,355 | $779 |
| Breo Ellipta | 41 | $16,209 | $395 |
| Daliresp | 25 | $14,666 | $587 |
| Anoro Ellipta | 26 | $12,471 | $480 |
| Advair Hfa | 19 | $11,286 | $594 |
| Advair Diskus | 17 | $7,655 | $450 |
| Incruse Ellipta | 22 | $7,434 | $338 |
| Stiolto Respimat | 13 | $5,408 | $416 |
| Montelukast | 219 | $3,107 | $14 |
| Arnuity Ellipta | 12 | $2,761 | $230 |
| Ventolin Hfa | 37 | $2,258 | $61 |
| Fluticasone Propionate | 21 | $284 | $14 |
| Prednisone | 31 | $194 | $6 |
| Azithromycin | 18 | $100 | $6 |
2018: 25 drugs
| Xolair | 13 | $90,846 | $6,988 |
| Symbicort | 167 | $64,588 | $387 |
| Spiriva Respimat | 77 | $42,311 | $549 |
| Spiriva | 74 | $41,027 | $554 |
| Anoro Ellipta | 67 | $34,352 | $513 |
| Breo Ellipta | 80 | $31,488 | $394 |
| Advair Diskus | 51 | $30,782 | $604 |
| Daliresp | 57 | $23,471 | $412 |
| Stiolto Respimat | 33 | $15,219 | $461 |
| Advair Hfa | 14 | $14,706 | $1,050 |
| Combivent Respimat | 23 | $13,070 | $568 |
| Trelegy Ellipta | 21 | $11,587 | $552 |
| Arnuity Ellipta | 38 | $10,222 | $269 |
| Incruse Ellipta | 21 | $8,148 | $388 |
| Flovent Hfa | 12 | $7,665 | $639 |
| Montelukast | 377 | $5,693 | $15 |
| Ventolin Hfa | 47 | $2,702 | $57 |
| Proair Hfa | 29 | $2,562 | $88 |
| Levalbuterol Tartrate Hfa | 19 | $1,711 | $90 |
| Xopenex Hfa | 20 | $1,649 | $82 |
| Pramipexole Dihydrochloride | 34 | $760 | $22 |
| Azithromycin | 38 | $339 | $9 |
| Prednisone | 40 | $299 | $7 |
| Fluticasone Propionate | 25 | $295 | $12 |
| Ranitidine | 15 | $246 | $16 |
2017: 29 drugs
| Ofev | 21 | $190,422 | $9,068 |
| Symbicort | 158 | $64,634 | $409 |
| Spiriva Respimat | 72 | $40,413 | $561 |
| Anoro Ellipta | 91 | $36,169 | $397 |
| Spiriva | 59 | $32,180 | $545 |
| Breo Ellipta | 85 | $31,159 | $367 |
| Advair Diskus | 43 | $23,997 | $558 |
| Daliresp | 47 | $18,605 | $396 |
| Stiolto Respimat | 30 | $12,656 | $422 |
| Advair Hfa | 15 | $12,221 | $815 |
| Combivent Respimat | 26 | $12,209 | $470 |
| Arnuity Ellipta | 42 | $9,564 | $228 |
| Dulera | 14 | $8,820 | $630 |
| Flovent Hfa | 12 | $6,250 | $521 |
| Montelukast | 379 | $5,850 | $15 |
| Incruse Ellipta | 15 | $5,699 | $380 |
| Qvar | 12 | $3,155 | $263 |
| Proair Hfa | 43 | $2,952 | $69 |
| Armodafinil | 12 | $2,015 | $168 |
| Levalbuterol Tartrate Hfa | 28 | $1,807 | $65 |
| Ventolin Hfa | 31 | $1,645 | $53 |
| Xopenex Hfa | 14 | $1,348 | $96 |
| Pramipexole Dihydrochloride | 39 | $707 | $18 |
| Ranitidine | 46 | $495 | $11 |
| Prednisone | 69 | $477 | $7 |
| Azithromycin | 62 | $443 | $7 |
| Fluticasone Propionate | 33 | $426 | $13 |
| Amoxicillin-Clavulanate Potass | 11 | $249 | $23 |
| Rifampin | 11 | $137 | $12 |
2016: 26 drugs
| Ofev | 16 | $137,793 | $8,612 |
| Esbriet | 11 | $87,761 | $7,978 |
| Symbicort | 139 | $48,643 | $350 |
| Spiriva | 82 | $38,943 | $475 |
| Advair Diskus | 54 | $27,889 | $516 |
| Spiriva Respimat | 57 | $23,965 | $420 |
| Breo Ellipta | 63 | $21,576 | $342 |
| Daliresp | 39 | $15,152 | $389 |
| Tudorza Pressair | 28 | $10,632 | $380 |
| Dulera | 18 | $9,926 | $551 |
| Combivent Respimat | 26 | $8,828 | $340 |
| Flovent Hfa | 15 | $8,601 | $573 |
| Anoro Ellipta | 21 | $8,010 | $381 |
| Stiolto Respimat | 19 | $5,992 | $315 |
| Montelukast | 344 | $5,528 | $16 |
| Arnuity Ellipta | 14 | $3,437 | $245 |
| Proair Hfa | 40 | $2,779 | $69 |
| Ventolin Hfa | 33 | $1,851 | $56 |
| Xopenex Hfa | 17 | $1,146 | $67 |
| Pramipexole Dihydrochloride | 43 | $667 | $16 |
| Fluticasone Propionate | 35 | $502 | $14 |
| Ranitidine | 35 | $482 | $14 |
| Prednisone | 49 | $394 | $8 |
| Azithromycin | 30 | $328 | $11 |
| Ipratropium | 14 | $323 | $23 |
| Omeprazole | 18 | $139 | $8 |
2015: 19 drugs
| Esbriet | 12 | $98,091 | $8,174 |
| Symbicort | 124 | $39,249 | $317 |
| Spiriva | 89 | $35,687 | $401 |
| Advair Diskus | 73 | $27,376 | $375 |
| Tudorza Pressair | 63 | $21,092 | $335 |
| Dulera | 57 | $19,065 | $334 |
| Spiriva Respimat | 41 | $15,425 | $376 |
| Combivent Respimat | 21 | $6,052 | $288 |
| Asmanex | 18 | $4,950 | $275 |
| Daliresp | 18 | $4,792 | $266 |
| Montelukast | 257 | $4,318 | $17 |
| Breo Ellipta | 11 | $3,675 | $334 |
| Proair Hfa | 41 | $2,955 | $72 |
| Pramipexole Dihydrochloride | 56 | $806 | $14 |
| Prednisone | 67 | $520 | $8 |
| Fluticasone Propionate | 32 | $386 | $12 |
| Ipratropium | 15 | $376 | $25 |
| Azithromycin | 37 | $286 | $8 |
| Omeprazole | 19 | $143 | $8 |
2014: 16 drugs
| Spiriva | 98 | $37,315 | $381 |
| Advair Diskus | 59 | $22,352 | $379 |
| Dulera | 71 | $20,945 | $295 |
| Symbicort | 75 | $20,927 | $279 |
| Tudorza Pressair | 48 | $14,318 | $298 |
| Montelukast | 230 | $5,556 | $24 |
| Combivent Respimat | 15 | $4,190 | $279 |
| Atrovent Hfa | 13 | $3,787 | $291 |
| Proair Hfa | 41 | $2,697 | $66 |
| Prednisone | 76 | $665 | $9 |
| Pramipexole Dihydrochloride | 46 | $604 | $13 |
| Azithromycin | 40 | $529 | $13 |
| Amox Tr-Potassium Clavulanate | 16 | $375 | $23 |
| Omeprazole | 19 | $352 | $19 |
| Fluticasone Propionate | 17 | $244 | $14 |
| Sulfamethoxazole-Trimethoprim | 11 | $178 | $16 |
2013: 16 drugs
| Spiriva | 108 | $41,893 | $388 |
| Advair Diskus | 56 | $22,219 | $397 |
| Dulera | 41 | $11,268 | $275 |
| Symbicort | 39 | $10,251 | $263 |
| Montelukast | 157 | $7,660 | $49 |
| Advair Hfa | 20 | $6,747 | $337 |
| Atrovent Hfa | 12 | $5,559 | $463 |
| Tudorza Pressair | 14 | $3,983 | $285 |
| Zafirlukast | 11 | $1,585 | $144 |
| Proair Hfa | 18 | $1,316 | $73 |
| Pramipexole Dihydrochloride | 22 | $1,248 | $57 |
| Fluticasone Propionate | 15 | $675 | $45 |
| Ventolin Hfa | 14 | $589 | $42 |
| Azithromycin | 35 | $515 | $15 |
| Omeprazole | 16 | $327 | $20 |
| Prednisone | 59 | $309 | $5 |
Money from drug and device companies
$5,747 in 2025
| 2025 | 21 | 225 | None | $5,747 |
| 2024 | 18 | 187 | None | $4,854 |
| 2023 | 14 | 174 | None | $4,676 |
| 2022 | 18 | 157 | None | $4,569 |
| 2021 | 18 | 118 | $1,380 | $4,022 |
| 2020 | 12 | 66 | None | $1,338 |
| 2019 | 15 | 71 | None | $1,465 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Tezspire | $1,290 | 41 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $1,034 | 52 payments
|
| Genzyme | Dupixent | $632 | 19 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $478 | 15 payments
|
| Regeneron Healthcare Solutions | Dupixent | $459 | 16 payments
|
| Amgen | Tezspire | $296 | 11 payments
|
See all 208 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-19 | Airsupra | $31 |
| GlaxoSmithKline | Meals · 2025-12-17 | Trelegy Ellipta | $10 |
| Regeneron Healthcare Solutions | Meals · 2025-12-17 | Dupixent | $28 |
| GlaxoSmithKline | Meals · 2025-12-16 | Nucala | $8 |
| Electromed | Meals · 2025-12-16 | Smartvest | $16 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-15 | Jascayd | $29 |
| Philips North America | Meals · 2025-12-11 | Vest Therapy Und | $24 |
| Genzyme | Meals · 2025-12-10 | Dupixent | $26 |
| GlaxoSmithKline | Meals · 2025-12-09 | Trelegy Ellipta | $34 |
| Amgen | Meals · 2025-12-08 | Tezspire | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-05 | Fasenra | $28 |
| GlaxoSmithKline | Meals · 2025-12-04 | Nucala | $28 |
| Insmed | Meals · 2025-12-02 | Arikayce | $35 |
| GlaxoSmithKline | Meals · 2025-12-02 | Trelegy Ellipta | $28 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-11-24 | Jascayd | $26 |
| Inspire Medical Systems | Meals · 2025-11-21 | Inspire | $35 |
| GlaxoSmithKline | Meals · 2025-11-19 | Trelegy Ellipta | $21 |
| Regeneron Healthcare Solutions | Meals · 2025-11-17 | Dupixent | $23 |
| GlaxoSmithKline | Meals · 2025-11-15 | Nucala | $25 |
| Amgen | Meals · 2025-11-13 | Tezspire | $32 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-08 | Airsupra | $32 |
| GlaxoSmithKline | Meals · 2025-11-07 | Trelegy Ellipta | $10 |
| GlaxoSmithKline | Meals · 2025-11-07 | Nucala | $11 |
| Verona Pharma | Meals · 2025-11-04 | Ohtuvayre | $3 |
| Verona Pharma | Meals · 2025-11-04 | Ohtuvayre | $14 |
| United Therapeutics | Meals · 2025-11-03 | Tyvaso | $27 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-31 | Jascayd | $35 |
| Philips North America | Meals · 2025-10-30 | Vest Therapy Und | $23 |
| Verona Pharma | Meals · 2025-10-29 | Ohtuvayre | $32 |
| GlaxoSmithKline | Meals · 2025-10-24 | Trelegy Ellipta | $9 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-24 | Tezspire | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-24 | Tezspire | $14 |
| GlaxoSmithKline | Meals · 2025-10-23 | Nucala | $18 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-22 | Jascayd | $33 |
| Inspire Medical Systems | Meals · 2025-10-22 | Inspire | $16 |
| GlaxoSmithKline | Meals · 2025-10-21 | Trelegy Ellipta | $10 |
| Regeneron Healthcare Solutions | Meals · 2025-10-21 | Dupixent | $35 |
| GlaxoSmithKline | Meals · 2025-10-18 | Trelegy Ellipta | $29 |
| Lilly USA | Meals · 2025-10-16 | Zepbound | $11 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-16 | Fasenra | $30 |
| Genzyme | Meals · 2025-10-16 | Dupixent | $6 |
| GlaxoSmithKline | Meals · 2025-10-15 | Nucala | $26 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-14 | Jascayd | $33 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-13 | Tezspire | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-10 | Fasenra | $24 |
| GlaxoSmithKline | Meals · 2025-10-08 | Nucala | $20 |
| Philips North America | Meals · 2025-10-08 | Vest Therapy Und | $11 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-07 | Breztri | $24 |
| GlaxoSmithKline | Meals · 2025-10-03 | Shingrix | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-10-03 | Dupixent | $80 |
| Philips North America | Meals · 2025-10-03 | Vest Therapy Und | $9 |
| Amgen | Meals · 2025-10-02 | Tezspire | $25 |
| Baxter Healthcare | Meals · 2025-10-01 | Hillrom - Monarch Airway Clearance System | $30 |
| Electromed | Meals · 2025-09-30 | Smartvest | $15 |
| Philips North America | Meals · 2025-09-29 | Vest Therapy Und | $21 |
| GlaxoSmithKline | Meals · 2025-09-26 | Nucala | $11 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-26 | Tezspire | $16 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-09-26 | Ofev | $39 |
| Inspire Medical Systems | Meals · 2025-09-25 | Inspire | $32 |
| Philips North America | Meals · 2025-09-24 | Vest Therapy Und | $12 |
| Regeneron Healthcare Solutions | Education · 2025-09-22 | Dupixent | $3 |
| GlaxoSmithKline | Meals · 2025-09-19 | Nucala | $26 |
| Lilly USA | Meals · 2025-09-15 | Zepbound | $33 |
| GlaxoSmithKline | Meals · 2025-09-12 | Trelegy Ellipta | $25 |
| GlaxoSmithKline | Meals · 2025-09-11 | Nucala | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-10 | Fasenra | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-10 | Airsupra | $32 |
| Amgen | Education · 2025-09-09 | None | $34 |
| GlaxoSmithKline | Meals · 2025-09-05 | Trelegy Ellipta | $35 |
| Philips North America | Meals · 2025-09-04 | Vest Therapy Und | $9 |
| Regeneron Healthcare Solutions | Meals · 2025-09-03 | Dupixent | $23 |
| Genzyme | Meals · 2025-08-29 | Dupixent | $33 |
| Philips North America | Meals · 2025-08-28 | Vest Therapy Und | $31 |
| GlaxoSmithKline | Meals · 2025-08-27 | Nucala | $7 |
| Regeneron Healthcare Solutions | Meals · 2025-08-27 | Dupixent | $30 |
| Insmed | Meals · 2025-08-26 | Arikayce | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-25 | Tezspire | $33 |
| Sanofi-Aventis U.S. | Education · 2025-08-21 | Dupixent | $93 |
| Genzyme | Meals · 2025-08-21 | Dupixent | $48 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-20 | Fasenra | $26 |
| Amgen | Meals · 2025-08-20 | Tezspire | $20 |
| Philips North America | Meals · 2025-08-20 | Vest Therapy Und | $8 |
| GlaxoSmithKline | Meals · 2025-08-18 | Nucala | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-15 | Fasenra | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-14 | None | $100 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-08-14 | Ofev | $29 |
| Baxter Healthcare | Meals · 2025-08-12 | Hillrom - Monarch Airway Clearance System | $28 |
| Verona Pharma | Meals · 2025-08-12 | Ohtuvayre | $30 |
| Lilly USA | Meals · 2025-08-11 | Zepbound | $11 |
| GlaxoSmithKline | Meals · 2025-08-09 | Trelegy Ellipta | $34 |
| Amgen | Education · 2025-08-08 | None | $34 |
| Genzyme | Meals · 2025-08-08 | Dupixent | $95 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-01 | Breztri | $17 |
| Amgen | Meals · 2025-08-01 | Tezspire | $6 |
| Philips North America | Meals · 2025-08-01 | Vest Therapy Und | $8 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-31 | Tezspire | $26 |
| GlaxoSmithKline | Meals · 2025-07-30 | Trelegy Ellipta | $23 |
| GlaxoSmithKline | Meals · 2025-07-29 | Nucala | $17 |
| GlaxoSmithKline | Meals · 2025-07-25 | Nucala | $25 |
| Regeneron Healthcare Solutions | Meals · 2025-07-24 | Dupixent | $14 |
| Amgen | Meals · 2025-07-24 | Tezspire | $30 |
| Novartis Pharmaceuticals | Meals · 2025-07-23 | Xolair | $34 |
| Lilly USA | Meals · 2025-07-22 | Zepbound | $30 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-07-21 | Ofev | $34 |
| GlaxoSmithKline | Meals · 2025-07-17 | Nucala | $9 |
| GlaxoSmithKline | Meals · 2025-07-17 | Trelegy Ellipta | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-17 | Airsupra | $21 |
| Philips North America | Meals · 2025-07-16 | Vest Therapy Und | $11 |
| Genzyme | Meals · 2025-07-16 | Dupixent | $30 |
| Verona Pharma | Meals · 2025-07-15 | Ohtuvayre | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-14 | Fasenra | $34 |
| Jazz Pharmaceuticals | Meals · 2025-07-11 | Xywav | $34 |
| Genzyme | Meals · 2025-07-09 | Dupixent | $36 |
| GlaxoSmithKline | Meals · 2025-06-18 | Nucala | $23 |
| GlaxoSmithKline | Meals · 2025-06-17 | Nucala | $34 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-06-16 | Ofev | $34 |
| GlaxoSmithKline | Meals · 2025-06-13 | Trelegy Ellipta | $34 |
| Regeneron Healthcare Solutions | Meals · 2025-06-10 | Dupixent | $38 |
| GlaxoSmithKline | Meals · 2025-06-06 | Nucala | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-05 | Fasenra | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-05 | Airsupra | $14 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-04 | Fasenra | $32 |
| Verona Pharma | Meals · 2025-06-03 | Ohtuvayre | $31 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-02 | Tezspire | $32 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-06-02 | Ofev | $30 |
| Amgen | Meals · 2025-05-29 | Tezspire | $34 |
| GlaxoSmithKline | Meals · 2025-05-23 | Trelegy Ellipta | $17 |
| GlaxoSmithKline | Meals · 2025-05-22 | Nucala | $10 |
| GlaxoSmithKline | Meals · 2025-05-22 | Nucala | $8 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-22 | Airsupra | $34 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-21 | Fasenra | $26 |
| GlaxoSmithKline | Meals · 2025-05-19 | Nucala | $32 |
| GlaxoSmithKline | Meals · 2025-05-16 | Trelegy Ellipta | $31 |
| Harmony Biosciences | Meals · 2025-05-15 | Wakix | $39 |
| Baxter Healthcare | Meals · 2025-05-14 | Hillrom - Monarch Airway Clearance System | $24 |
| Lilly USA | Meals · 2025-05-13 | Zepbound | $30 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-12 | Ofev | $35 |
| Genzyme | Meals · 2025-05-12 | Dupixent | $30 |
| Genzyme | Meals · 2025-05-09 | Dupixent | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-05-08 | Dupixent | $6 |
| Philips North America | Meals · 2025-05-08 | Vest Therapy Und | $28 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-07 | Ofev | $28 |
| Verona Pharma | Meals · 2025-05-06 | Ohtuvayre | $32 |
| Lilly USA | Meals · 2025-05-05 | Zepbound | $7 |
| Regeneron Healthcare Solutions | Meals · 2025-04-30 | Dupixent | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-29 | Tezspire | $31 |
| United Therapeutics | Meals · 2025-04-28 | Tyvaso | $17 |
| GlaxoSmithKline | Meals · 2025-04-25 | Nucala | $3 |
| Regeneron Healthcare Solutions | Meals · 2025-04-25 | Dupixent | $37 |
| GlaxoSmithKline | Meals · 2025-04-23 | Trelegy Ellipta | $16 |
| Verona Pharma | Meals · 2025-04-22 | Ohtuvayre | $25 |
| Genzyme | Meals · 2025-04-16 | Wayrilz | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-04-15 | Dupixent | $37 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-14 | Tezspire | $27 |
| Genzyme | Meals · 2025-04-10 | Dupixent | $31 |
| GlaxoSmithKline | Meals · 2025-04-09 | Nucala | $19 |
| GlaxoSmithKline | Meals · 2025-04-09 | Nucala | $7 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-07 | Fasenra | $32 |
| Genzyme | Meals · 2025-04-02 | Dupixent | $46 |
| Noctrix Health | Meals · 2025-04-01 | Nidra | $149 |
| Amgen | Meals · 2025-03-31 | Tezspire | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-28 | Tezspire | $22 |
| GlaxoSmithKline | Meals · 2025-03-27 | Trelegy Ellipta | $29 |
| Lilly USA | Meals · 2025-03-25 | Zepbound | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-24 | Fasenra | $25 |
| Philips North America | Meals · 2025-03-19 | Vest Therapy Und | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-18 | Tezspire | $31 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-03-17 | Ofev | $33 |
| Genzyme | Meals · 2025-03-17 | Dupixent | $34 |
| GlaxoSmithKline | Meals · 2025-03-14 | Nucala | $29 |
| Resmed | Meals · 2025-03-13 | Airsense | $23 |
| Genzyme | Meals · 2025-03-13 | Dupixent | $32 |
| GlaxoSmithKline | Meals · 2025-03-11 | Trelegy Ellipta | $24 |
| Insmed | Meals · 2025-03-10 | Arikayce | $25 |
| Genzyme | Meals · 2025-03-05 | Dupixent | $38 |
| Regeneron Healthcare Solutions | Meals · 2025-03-04 | Dupixent | $31 |
| GlaxoSmithKline | Meals · 2025-02-28 | Nucala | $10 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-28 | Fasenra | $27 |
| Genzyme | Meals · 2025-02-28 | Dupixent | $27 |
| GlaxoSmithKline | Meals · 2025-02-27 | Trelegy Ellipta | $23 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-02-21 | Ofev | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-20 | Fasenra | $30 |
| Amgen | Meals · 2025-02-18 | Tezspire | $24 |
| Verona Pharma | Meals · 2025-02-17 | Ohtuvayre | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-15 | Airsupra | $34 |
| GlaxoSmithKline | Meals · 2025-02-13 | Nucala | $9 |
| Philips North America | Meals · 2025-02-13 | Vest Therapy Und | $25 |
| Genzyme | Meals · 2025-02-13 | Dupixent | $18 |
| Genzyme | Meals · 2025-02-13 | Dupixent | $9 |
| Regeneron Healthcare Solutions | Meals · 2025-02-07 | Dupixent | $33 |
| Abbvie | Meals · 2025-02-05 | Vraylar | $125 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-04 | Fasenra | $23 |
| Genzyme | Meals · 2025-02-04 | Dupixent | $37 |
| Philips North America | Meals · 2025-01-31 | Patient Interface Software | $52 |
| GlaxoSmithKline | Meals · 2025-01-30 | Trelegy Ellipta | $25 |
| Lilly USA | Meals · 2025-01-29 | Zepbound | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-28 | Fasenra | $30 |
| Harmony Biosciences | Meals · 2025-01-27 | Wakix | $30 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-21 | Tezspire | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-18 | Tezspire | $170 |
| GlaxoSmithKline | Meals · 2025-01-17 | Trelegy Ellipta | $13 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-17 | Fasenra | $27 |
| Electromed | Meals · 2025-01-17 | Smartvest | $19 |
| GlaxoSmithKline | Meals · 2025-01-15 | Trelegy Ellipta | $19 |
| GlaxoSmithKline | Meals · 2025-01-13 | Nucala | $10 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-01-09 | Ofev | $35 |
| Regeneron Healthcare Solutions | Meals · 2025-01-08 | Dupixent | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-06 | None | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $4,854
| AstraZeneca Pharmaceuticals LP | Fasenra | $1,056 | 36 payments
|
| GlaxoSmithKline | Nucala | $811 | 41 payments
|
| Philips North America | (8269) Dreamstation Cpap | $765 | 7 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $661 | 26 payments
|
| Genzyme | Dupixent | $494 | 18 payments
|
| Regeneron Healthcare Solutions | Dupixent | $357 | 11 payments
|
| Baxter Healthcare | Hillrom - Vest System Model 105 Home Care | $128 | 5 payments
|
| Harmony Biosciences | Wakix | $119 | 3 payments
|
| Amgen | Tezspire | $105 | 4 payments
|
| Sanofi-Aventis U.S. | Dupixent | $79 | 1 payment
|
| Inspire Medical Systems | Inspire | $52 | 1 payment
|
| Insmed | Arikayce | $49 | 2 payments
|
| Grifols USA | Prolastin-C Liquid | $46 | 2 payments
|
| Electromed | Smartvest | $44 | 2 payments
|
| Merck Sharp & Dohme | None | $24 | 1 payment
|
| United Therapeutics | Tyvaso | $23 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $23 | 1 payment
|
| Avadel CNS Pharmaceuticals | Lumryz | $18 | 1 payment
|
2023: $4,676
| Philips Electronics North America | (8269) Dreamstation Cpap | $1,178 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $1,096 | 40 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $819 | 41 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $623 | 24 payments
|
| Genzyme | Dupixent | $319 | 13 payments
|
| Baxter Healthcare | Hillrom - Life 2000 Ventilation System | $145 | 8 payments
|
| Regeneron Healthcare Solutions | Dupixent | $112 | 2 payments
|
| Novartis Pharmaceuticals | Xolair | $76 | 3 payments
|
| Sanofi-Aventis U.S. | Dupixent | $75 | 1 payment
|
| Electromed | Smartvest | $64 | 3 payments
|
| Harmony Biosciences | Wakix | $57 | 2 payments
|
| Grifols USA | Prolastin-C Liquid | $51 | 3 payments
|
| CSL Behring | Kcentra | $32 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Glassia | $27 | 1 payment
|
2022: $4,569
| Philips Electronics North America | (8269) Dreamstation Cpap | $1,087 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $786 | 39 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $679 | 29 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $600 | 25 payments
|
| Genzyme | Dupixent | $324 | 13 payments
|
| Hologic | 3dquorum | $197 | 1 payment
|
| Harmony Biosciences | Wakix | $161 | 7 payments
|
| Regeneron Healthcare Solutions | Dupixent | $133 | 1 payment
|
| Baxter Healthcare | Hillrom - Life 2000 Ventilation System | $124 | 11 payments
|
| Sanofi-Aventis U.S. | Dupixent | $97 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $86 | 4 payments
|
| Genentech USA | Xolair | $76 | 3 payments
|
| Grifols USA | Prolastin-C Liquid | $75 | 4 payments
|
| Amgen | Tezspire | $44 | 2 payments
|
| CSL Behring | Kcentra | $35 | 2 payments
|
| Electromed | Smartvest | $28 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $24 | 1 payment
|
| Fisher & Paykel Healthcare | Fisher & Paykel Healthcare | $15 | 1 payment
|
2021: $4,022
| Apria Healthcare | Resmed | $1,380 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $558 | 21 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $554 | 26 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $410 | 21 payments
|
| Harmony Biosciences | Wakix | $252 | 8 payments
|
| Genzyme | Dupixent | $185 | 10 payments
|
| Mallinckrodt Hospital Products | Acthar | $133 | 6 payments
|
| Philips Electronics North America | (8356) Dreamwear Cushions | $129 | 5 payments
|
| Grifols USA | Prolastin-C Liquid | $91 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Aralast | $89 | 3 payments
|
| Genentech USA | Xolair | $48 | 2 payments
|
| Jazz Pharmaceuticals | Xywav | $46 | 2 payments
|
| Advanced Respiratory | Volara System | $34 | 1 payment
|
| CSL Behring | Kcentra | $32 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $23 | 1 payment
|
| Resmed | Airsense | $21 | 1 payment
|
| Electromed | Smartvest | $21 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $17 | 1 payment
|
2020: $1,338
| GlaxoSmithKline | Trelegy Ellipta | $437 | 23 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $286 | 13 payments
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $277 | 14 payments
|
| Takeda Pharmaceuticals U.S.A. | Glassia | $76 | 3 payments
|
| Genzyme | Dupixent | $71 | 3 payments
|
| Grifols USA | Prolastin-C Liquid | $44 | 2 payments
|
| Advanced Respiratory | The Vest System Model 105 Home Care | $36 | 2 payments
|
| Sanofi-Aventis U.S. | Dupixent | $32 | 1 payment
|
| Resmed | Astral | $31 | 1 payment
|
| CSL Behring | Haegarda | $19 | 1 payment
|
| Philips Electronics North America | (2660) Lab Full Face | $14 | 1 payment
|
| Jazz Pharmaceuticals | Sunosi | $12 | 1 payment
|
2019: $1,465
| AstraZeneca Pharmaceuticals LP | Symbicort | $279 | 15 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $249 | 12 payments
|
| Philips Electronics North America | Trilogy 100 | $245 | 8 payments
|
| GlaxoSmithKline | Nucala | $227 | 15 payments
|
| Genzyme | Dupixent | $87 | 4 payments
|
| Grifols USA | Prolastin-C Liquid | $73 | 3 payments
|
| Shire North American Group | Glassia | $72 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $51 | 2 payments
|
| Genentech USA | Xolair | $37 | 2 payments
|
| Advanced Respiratory | The Vest System Model 105 Home Care | $34 | 2 payments
|
| Sanofi-Aventis U.S. | Dupixent | $29 | 1 payment
|
| Avanir Pharmaceuticals | Nuedexta | $24 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $23 | 1 payment
|
| Genentech | Xolair | $18 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $17 | 1 payment
|
Professional record
- NPI
- 1528021490
- Licence
- CA A79456California A79456: Current · expires 2027-08-31
- Trained
- University of Vermont College of Medicine, 1996
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RS0012X (207RS0012X); Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 4810 Kieran Ct, Santa Rosa, CA, 95405
- NPI first listed
- 2006-04-10
- NPI last updated
- 2020-04-06
- NPI record certified
- 2020-04-06
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 501 Petaluma Ave, Sebastopol, CA, 95472